Lizzy Smyth

@lizzysmyth.bsky.social

Oncologist. Cancer Research 👩‍⚕️. Clinical Trials 🧬💊. Oxford Irish. #Oncsky

We've spent 2024 discussing RT trial results in gastroesophageal cancer. My radiation oncology mate Som helps me make sense of it all below... 2024 Top Story in Oncology: The Role of Radiotherapy in Operable Gastro-Oesophageal and Gastric Cancer — Time for Change prac.co/l/22cfph7u

2024 Top Story in Oncology: The Role of Radiotherapy in Operable Gastro-Oesophageal and Gastric Cancer — Time for Change

Written by Elizabeth Smyth MD Written by Somnath Mukherjee MD, MRCP, FRCR, FRCP

prac.co

Twitter, as we knew it, is gone, stained by new horrific algorithms that promote misinformation. 🦋 is a much better place for those interested in science. And it’s growing fast. Thanks @jamiedoggett for highlighting our efforts to rebuild a safe place for scientific discussion.

Jamie Doggett@jamiedoggett.bsky.social · 2y ago

Bluesky or X: The role influential HCPs will play in ‘stay, go or double-up’ cannot be underestimated. With #ASH24 and #SABCS2024 just around the corner, this is an interesting moment for health conversation on socials. @ptarantinomd.bsky.social #MedTwitter #MedSky www.linkedin.com/pulse/role-h...

Good to see our protocol paper for DECIPHER in press at ESMO GO! ctDNA 🧬 after surgery will detect pts with HER2➕ gastroesophageal #cancer at high risk of recurring 🧬➕ receive TDxD instead of usual post-op chemo Hope to #cure some micrometastatic cancers 🙏 www.sciencedirect.com/science/arti...

Evaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER

Operable gastrooesophageal adenocarcinoma (GOA) is treated with multimodality therapy which is curative in <50% of patients. Patients in the UK with o…

sciencedirect.com

www.nature.com/articles/s41... Sharing our latest review article to highlight the importance of appropriately developing combination strategies for immune checkpoint therapy. Grateful for working with 3 brilliant scientists: Sangeeta Goswami, Kristen Pauken & Linghua Wang

Next-generation combination approaches for immune checkpoint therapy - Nature Immunology

In this Review, Sharma and colleagues describe the current landscape of combination therapies and discuss requirements for the development of effective combination strategies.

nature.com

November is gastric cancer awareness month and we are sharing updates in the field ⭐ At #ESMO24, we spoke with Jessie Elliott on long-term survivorship concerns of patients with esophageal and gastric cancer. 👉See the video below! 👈 https://buff.ly/48WQh5R #stcsm #gism

Long-term survivorship concerns of patients with esophageal and gastric cancer - VJOncology

Jessie Elliott, FRCS, PhD, Trinity St. James’s Cancer Institute, Dublin, Ireland, discusses the long-term survivorship concerns of patients with esophageal...

buff.ly

❓ Should we switch chemotherapy for patients with gastroesophageal cancer after 3 months? ARMANI trial published in Lancet Oncol today ✔️ Patients who switched to 2L pac/ram after 3m of OxFU had ⬆️ PFS and OS than patients who continued 1L chemo ❌....but also ⬆️ hospital visits & toxicity.

Bild

Inspired by the other amazing starter packs - here's one for cancer researchers! I tried to make this broad - from immunology to genomics to cell biology and so much more.. This list also includes organizations & institutes supporting cancer researchers 🧪🔬⚕️🩺 Hope its useful! go.bsky.app/FEoaJMc

Post nicht verfügbar.